Navigation Links
Researchers Find Potential Link Between Drinking Alcohol And Breast Cancer
Date:4/23/2012

SAN DIEGO, April 23, 2012 /PRNewswire-USNewswire/ -- A research team this week will present findings that they say may finally explain the link between alcohol consumption and breast cancer.

"Cells have different mechanisms to remove toxic substances, such as ethanol, the chemical name for alcohol, that represent a potential risk to them," explains Maria de Lourdes Rodriguez-Fragoso, professor of pharmacology and toxicology at the Universidad Autonoma del Estado de Morelos in Mexico. "Unfortunately, sometimes these mechanisms produce other toxic substances, including some that are associated with the development of different types of cancer."

At 12:25 p.m. Monday, April 23, Rodriguez-Fragoso will present her group's work at the annual meeting of the American Society for Biochemistry and Molecular Biology, held in conjunction with the Experimental Biology 2012 conference in San Diego.

Alcohol consumption has long been established as a risk factor for breast cancer. But finding the direct link that makes it so has, so far, proved elusive. Now, Rodriguez-Fragoso and her collaborators think that they have found the answer, a protein called CYP2E1.

"We knew that CYP2E1 could break down ethanol and that doing so created unstable, highly reactive chemicals known as free radicals," she says. Working with researcher Scott Burchiel and his group at the University of New Mexico, Rodriguez-Fragoso's team had previously found that free radicals were associated with activation of cellular mechanisms that lead to tumor development. "The question then was, does having more CYP2E1 make you more susceptible to ethanol-induced toxicity, thereby increasing your risk of developing cancer?"

CYP2E1 is found in breast cells known as mammary epithelial cells, which are also where most breast cancers originate, suggesting to the researchers that CYP2E1 may be involved in breast cancer development. To test this hypothesis, the researchers administered ethanol to separate cultures of mammary epithelial cells that had varying levels of CYP2E1. Cells that expressed low levels of CYP2E1 were mostly immune to the effects of the ethanol treatment; however, cells with increased amounts of CYP2E1 protein were greatly affected, suggesting that women with higher expression levels of the protein would show similar responses.

Significantly, points out Rodriguez-Fragoso, "our results showed that ethanol-treated human mammary cells had an increase in free radical production, oxidative stress and the activation of cellular mechanisms that cause cells to increase their proliferation rate," all hallmarks of cancer. "So if you are a woman who naturally expresses higher levels of CYP2E1 and you consume alcohol, you would be at a greater risk for developing breast cancer than a woman who expresses lower amounts of CYP2E1," she explains.

A few months ago, the group started investigating CYP2E1 expression levels in breast tissue obtained from healthy women who had undergone mammaplasties. "Preliminary results show that there is great variability in the expression of this enzyme among the analyzed samples," says Rodriguez-Fragoso. "This means that each individual will have a different response to alcohol, and each should take different precautions to minimize their risk of developing breast cancer."

With these results in hand, Rodriguez-Fragoso expressed confidence that her group will be able to develop a method of diagnosis that would focus on the determination of expression levels of CYP2E1 in breast tissue. "If you know the risk probability of certain behaviors on your likelihood of developing cancer, then you can better understand what preventative measures you should be taking," she emphasizes.

The Center for Disease Control and Prevention estimates that breast cancer will be responsible for nearly 40,000 deaths this year alone, with an additional 220,000 diagnoses. "If we can prevent the development of breast cancer associated with alcohol intake by timely diagnoses of markers such as CYP2E1," says Rodriguez-Fragoso, "then the annual numbers of new cases and deaths could be diminished significantly."

About Experimental Biology 2012
Experimental Biology is an annual gathering of six scientific societies that this year is expected to draw 14,000-plus independent scientists and exhibitors. The American Society for Biochemistry and Molecular Biology (ASBMB) is a co-sponsor of the meeting, along with the American Association of Anatomists (AAA), American Physiological Society (APS), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN) and the American Society for Pharmacology and Experimental Therapeutics (ASPET).

More information about EB2012 for the media can be found on the press page: http://experimentalbiology.org/EB/pages/Press-Registration.aspx.

About the American Society for Biochemistry and Molecular Biology
The ASBMB is a nonprofit scientific and educational organization with more than 12,000 members worldwide. Most members teach and conduct research at colleges and universities. Others conduct research in various government laboratories, at nonprofit research institutions and in industry. The Society's student members attend undergraduate or graduate institutions. For more information about ASBMB, visit www.asbmb.org.

ONSITE NEWSROOM
San Diego Convention Center
April 21-April 25, 2012
Phone: 619-525-6213
Media@FASEB.org

Angela Hopp
Cell: 713.471.4541
Office: 240.283.6614
ahopp@asbmb.org


'/>"/>
SOURCE American Society for Biochemistry and Molecular Biology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Quality Standards Established for Competition to Identify Best Researchers in the US
2. Researchers reveal why some pain drugs become less effective over time
3. Researchers Identify New Regulator in Allergic Diseases
4. CNIO researchers take part in the most comprehensive personalized medicine study performed to date
5. Researchers develop graphene supercapacitor holding promise for portable electronics
6. Researchers capture first-ever images of atoms moving in a molecule
7. Penn researchers build first physical metatronic circuit
8. Pitt researchers coax gold into nanowires
9. York researchers create tornados inside electron microscopes
10. Self-assembling nanorods: Berkeley Lab researchers obtain 1-, 2- and 3-D nanorod arrays and networks
11. Navy researchers investigate small-scale autonomous planetary explorers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2020)... , ... May 04, 2020 , ... ... solutions for the life sciences industry, today announced that Informa Training Partners, a ... changing its name to Red Nucleus Boston, effective immediately. , “The name change ...
(Date:5/1/2020)... YORK (PRWEB) , ... April 30, 2020 , ... ... Awards were announced today, honoring the businesses, policies, projects, and concepts that are ... a revolutionary bioprinter for living cells, which has taken out the top prize ...
(Date:4/22/2020)... CAMBRIDGE, Mass. (PRWEB) , ... April 20, 2020 ... ... with US offices in Cambridge, MA, announced today that Omixon’s founder and chairman ... early commercialisation of Omixon’s flagship product Holotype HLA since 2014 before stepping into ...
(Date:4/18/2020)... (PRWEB) , ... April 17, 2020 , ... ... Science Foundation (NSF) Small Business Innovation Research (SBIR) program to support the expansion ... This funding from the NSF, which conducts a rigorous merit-based review process, ...
Breaking Biology Technology:
(Date:4/30/2020)... (PRWEB) , ... April 29, 2020 , ... ... well positioned for continued growth – delivering innovative solutions for a wide range ... chemical, aerospace and government agencies. A month into the new decade, it was ...
(Date:4/26/2020)... ... , ... A team of researchers at the Icahn School of Medicine at ... virus that causes coronavirus disease (COVID-19). This antibody is intended to block the virus ... , The efforts are being led by Mone Zaidi, MD, PhD, MACP, Director of ...
(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. ... firm that provides patent development support for early stage startups. The investment will ... as ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology. ...
Breaking Biology News(10 mins):